01 · Service

Healthcare M&A Advisory

Buy-side and sell-side guidance for practices, MSOs and platforms, from the first valuation to the day after close.

Sell-side

For owners ready to sell, partner or recapitalize

  • Valuation and readiness review before you go to market
  • A targeted buyer list: MSOs, private equity platforms, health systems
  • Negotiation on price, structure, earn-outs and your role after close

Buy-side

For MSOs, platforms and investors building scale

  • Target sourcing in Florida and national markets
  • Diligence on payer mix, value-based contracts and revenue cycle
  • Integration planning so providers stay after close

How it works

From first conversation to results

  1. Valuation & readiness

    Where your value comes from and what to fix first.

  2. Positioning & outreach

    A confidential profile to the right buyers or targets.

  3. LOI & negotiation

    Price, structure and terms that protect you.

  4. Diligence

    Organized data and answers so the deal keeps moving.

  5. Close & transition

    Integration support for providers, staff and patients.

Questions we hear

Don't see yours? Ask it on a call. There's no cost and no commitment.

Related services:

How long does a practice sale usually take?

It depends on deal size, buyer type and how ready your records are. We set a realistic timeline after the valuation and readiness review, and we keep it updated at every stage.

Will my staff and patients know I'm exploring a sale?

Not unless you want them to. Outreach uses a confidential profile, and buyers sign an NDA before they learn who you are.

How do value-based contracts affect my valuation?

Buyers look closely at payer mix, risk contracts and quality performance. Strong value-based results can raise interest, and we show you how buyers will read yours.

How are your fees structured?

Fees depend on the size and scope of the engagement. We walk through them on the first call, before you commit to anything.

Start with what your practice is worth.

Free, confidential, and reviewed by an M&A advisor.

Get a free valuation